Cargando…

Can Oncologists Prompt Patient Prognostic Awareness to Enhance Decision-Making? Data From the NEOetic Study

INTRODUCTION: Anti-neoplastic therapy improves the prognosis for advanced cancer, albeit it is not curative. An ethical dilemma that often arises during patients’ first appointment with the oncologist is to give them only the prognostic information they can tolerate, even at the cost of compromising...

Descripción completa

Detalles Bibliográficos
Autores principales: Carmona-Bayonas, Alberto, Rodriguez-Gonzalez, Adán, García-García, Teresa, Velasco-Durantez, Verónica, Hernández-San Gil, Raquel, Cruz-Castellanos, Patricia, Fernandez-Montes, Ana, Castillo-Trujillo, Alfredo, Ballester, Inmaculada, Rogado, Jacobo, Calderon, Caterina, Jimenez-Fonseca, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628594/
https://www.ncbi.nlm.nih.gov/pubmed/37185783
http://dx.doi.org/10.1093/oncolo/oyad100
_version_ 1785131793222991872
author Carmona-Bayonas, Alberto
Rodriguez-Gonzalez, Adán
García-García, Teresa
Velasco-Durantez, Verónica
Hernández-San Gil, Raquel
Cruz-Castellanos, Patricia
Fernandez-Montes, Ana
Castillo-Trujillo, Alfredo
Ballester, Inmaculada
Rogado, Jacobo
Calderon, Caterina
Jimenez-Fonseca, Paula
author_facet Carmona-Bayonas, Alberto
Rodriguez-Gonzalez, Adán
García-García, Teresa
Velasco-Durantez, Verónica
Hernández-San Gil, Raquel
Cruz-Castellanos, Patricia
Fernandez-Montes, Ana
Castillo-Trujillo, Alfredo
Ballester, Inmaculada
Rogado, Jacobo
Calderon, Caterina
Jimenez-Fonseca, Paula
author_sort Carmona-Bayonas, Alberto
collection PubMed
description INTRODUCTION: Anti-neoplastic therapy improves the prognosis for advanced cancer, albeit it is not curative. An ethical dilemma that often arises during patients’ first appointment with the oncologist is to give them only the prognostic information they can tolerate, even at the cost of compromising preference-based decision-making, versus giving them full information to force prompt prognostic awareness, at the risk of causing psychological harm. METHODS: We recruited 550 participants with advanced cancer. After the appointment, patients and clinicians completed several questionnaires about preferences, expectations, prognostic awareness, hope, psychological symptoms, and other treatment-related aspects. The aim was to characterize the prevalence, explanatory factors, and consequences of inaccurate prognostic awareness and interest in therapy. RESULTS: Inaccurate prognostic awareness affected 74%, conditioned by the administration of vague information without alluding to death (odds ratio [OR] 2.54; 95% CI, 1.47-4.37, adjusted P = .006). A full 68% agreed to low-efficacy therapies. Ethical and psychological factors oriented first-line decision-making, in a trade-off in which some lose quality of life and mood, for others to gain autonomy. Imprecise prognostic awareness was associated with greater interest in low-efficacy treatments (OR 2.27; 95% CI, 1.31-3.84; adjusted P = .017), whereas realistic understanding increased anxiety (OR 1.63; 95% CI, 1.01-2.65; adjusted P = 0.038), depression (OR 1.96; 95% CI, 1.23-3.11; adjusted P = .020), and diminished quality of life (OR 0.47; 95% CI, 0.29-0.75; adjusted P = .011). CONCLUSION: In the age of immunotherapy and targeted therapies, many appear not to understand that antineoplastic therapy is not curative. Within the mix of inputs that comprise inaccurate prognostic awareness, many psychosocial factors are as relevant as the physicians’ disclosure of information. Thus, the desire for better decision-making can actually harm the patient.
format Online
Article
Text
id pubmed-10628594
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106285942023-11-08 Can Oncologists Prompt Patient Prognostic Awareness to Enhance Decision-Making? Data From the NEOetic Study Carmona-Bayonas, Alberto Rodriguez-Gonzalez, Adán García-García, Teresa Velasco-Durantez, Verónica Hernández-San Gil, Raquel Cruz-Castellanos, Patricia Fernandez-Montes, Ana Castillo-Trujillo, Alfredo Ballester, Inmaculada Rogado, Jacobo Calderon, Caterina Jimenez-Fonseca, Paula Oncologist Medical Ethics INTRODUCTION: Anti-neoplastic therapy improves the prognosis for advanced cancer, albeit it is not curative. An ethical dilemma that often arises during patients’ first appointment with the oncologist is to give them only the prognostic information they can tolerate, even at the cost of compromising preference-based decision-making, versus giving them full information to force prompt prognostic awareness, at the risk of causing psychological harm. METHODS: We recruited 550 participants with advanced cancer. After the appointment, patients and clinicians completed several questionnaires about preferences, expectations, prognostic awareness, hope, psychological symptoms, and other treatment-related aspects. The aim was to characterize the prevalence, explanatory factors, and consequences of inaccurate prognostic awareness and interest in therapy. RESULTS: Inaccurate prognostic awareness affected 74%, conditioned by the administration of vague information without alluding to death (odds ratio [OR] 2.54; 95% CI, 1.47-4.37, adjusted P = .006). A full 68% agreed to low-efficacy therapies. Ethical and psychological factors oriented first-line decision-making, in a trade-off in which some lose quality of life and mood, for others to gain autonomy. Imprecise prognostic awareness was associated with greater interest in low-efficacy treatments (OR 2.27; 95% CI, 1.31-3.84; adjusted P = .017), whereas realistic understanding increased anxiety (OR 1.63; 95% CI, 1.01-2.65; adjusted P = 0.038), depression (OR 1.96; 95% CI, 1.23-3.11; adjusted P = .020), and diminished quality of life (OR 0.47; 95% CI, 0.29-0.75; adjusted P = .011). CONCLUSION: In the age of immunotherapy and targeted therapies, many appear not to understand that antineoplastic therapy is not curative. Within the mix of inputs that comprise inaccurate prognostic awareness, many psychosocial factors are as relevant as the physicians’ disclosure of information. Thus, the desire for better decision-making can actually harm the patient. Oxford University Press 2023-04-26 /pmc/articles/PMC10628594/ /pubmed/37185783 http://dx.doi.org/10.1093/oncolo/oyad100 Text en © The Author(s) 2023. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
spellingShingle Medical Ethics
Carmona-Bayonas, Alberto
Rodriguez-Gonzalez, Adán
García-García, Teresa
Velasco-Durantez, Verónica
Hernández-San Gil, Raquel
Cruz-Castellanos, Patricia
Fernandez-Montes, Ana
Castillo-Trujillo, Alfredo
Ballester, Inmaculada
Rogado, Jacobo
Calderon, Caterina
Jimenez-Fonseca, Paula
Can Oncologists Prompt Patient Prognostic Awareness to Enhance Decision-Making? Data From the NEOetic Study
title Can Oncologists Prompt Patient Prognostic Awareness to Enhance Decision-Making? Data From the NEOetic Study
title_full Can Oncologists Prompt Patient Prognostic Awareness to Enhance Decision-Making? Data From the NEOetic Study
title_fullStr Can Oncologists Prompt Patient Prognostic Awareness to Enhance Decision-Making? Data From the NEOetic Study
title_full_unstemmed Can Oncologists Prompt Patient Prognostic Awareness to Enhance Decision-Making? Data From the NEOetic Study
title_short Can Oncologists Prompt Patient Prognostic Awareness to Enhance Decision-Making? Data From the NEOetic Study
title_sort can oncologists prompt patient prognostic awareness to enhance decision-making? data from the neoetic study
topic Medical Ethics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628594/
https://www.ncbi.nlm.nih.gov/pubmed/37185783
http://dx.doi.org/10.1093/oncolo/oyad100
work_keys_str_mv AT carmonabayonasalberto canoncologistspromptpatientprognosticawarenesstoenhancedecisionmakingdatafromtheneoeticstudy
AT rodriguezgonzalezadan canoncologistspromptpatientprognosticawarenesstoenhancedecisionmakingdatafromtheneoeticstudy
AT garciagarciateresa canoncologistspromptpatientprognosticawarenesstoenhancedecisionmakingdatafromtheneoeticstudy
AT velascodurantezveronica canoncologistspromptpatientprognosticawarenesstoenhancedecisionmakingdatafromtheneoeticstudy
AT hernandezsangilraquel canoncologistspromptpatientprognosticawarenesstoenhancedecisionmakingdatafromtheneoeticstudy
AT cruzcastellanospatricia canoncologistspromptpatientprognosticawarenesstoenhancedecisionmakingdatafromtheneoeticstudy
AT fernandezmontesana canoncologistspromptpatientprognosticawarenesstoenhancedecisionmakingdatafromtheneoeticstudy
AT castillotrujilloalfredo canoncologistspromptpatientprognosticawarenesstoenhancedecisionmakingdatafromtheneoeticstudy
AT ballesterinmaculada canoncologistspromptpatientprognosticawarenesstoenhancedecisionmakingdatafromtheneoeticstudy
AT rogadojacobo canoncologistspromptpatientprognosticawarenesstoenhancedecisionmakingdatafromtheneoeticstudy
AT calderoncaterina canoncologistspromptpatientprognosticawarenesstoenhancedecisionmakingdatafromtheneoeticstudy
AT jimenezfonsecapaula canoncologistspromptpatientprognosticawarenesstoenhancedecisionmakingdatafromtheneoeticstudy